Table 4 Results of 3 pairwise comparisons of expanded virus groups, by use of least-squares means differences and the Tukey honestly significant difference.

Slides:

Advertisements

Similar presentations

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

Advertisements

Date of download: 7/6/2016 Copyright © 2016 SPIE. All rights reserved. Comparison between images obtained using SSOCT and ultrasound. 2-D cross-sectional.

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Figure 3 Escape into the cytosol and subsequent intracellular replication during an infection of J774 macrophages with Listeria monocytogenes ΔactA (diamonds),

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Figure 1. Varicella-related outpatient visit rates by age group, MarketScan 2003–2012. Varicella was the primary diagnosis code for data shown. Annual.

Figure 1. Disposition of study participants, by group. Data are no

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

From: Rotarix: A Rotavirus Vaccine for the World

Laboratory diagnosis and biosafety issues of biological warfare agents

Figure 3. Estimated liver parasite load on day 6

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Figure 1. Prevalence of undocumented hepatitis C virus (HCV) infection, by age, race, and sex in 4713 emergency department patients, From: Evaluation.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,

From: Postinfectious Irritable Bowel Syndrome

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Figure 2 In situ hybridization for rhinovirus type 14 (rhinovirus-14) in maxillary sinus biopsy specimens. A, Detection of rhinovirus-14, antisense probe,

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.

Table 2. Mean intrasubject diversity for the 11 study participants, by genomic region. From: Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects.

Liver abscess due to Bacillus cereus: a case report

R. Cavallo Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

J.-P. Van geertruyden Clinical Microbiology and Infection

Professional Organizations

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

A case of an abscess due to Salmonella serotype enteritidis behind the eye: a unique event as part of a growing food-borne problem in Belgium? T. Spiritus,

Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli R.A. Hickman, D. Hughes,

Recombinant mumps virus as a cancer therapeutic agent

Structure of grepafloxacin relative to activity and safety profile

P. Moreillon, J.M. Entenza Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

Figure 1. Overview of protein microarray titers for all hemagglutinin (HA) part antigens, by diet and species. Antigens ... Figure 1. Overview of protein.

M. Or, M. Samish, T. Waner, S. Harrus

Brain and spine MR imaging of a 48-year-old woman with Zika virus infection and encephalitis and myelitis. Brain and spine MR imaging of a 48-year-old.

Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product T.G. Bromage Clinical Microbiology.

Frequencies of lipopolysaccharide-defined epitopes in Haemophilus influenzae type b and non-typable isolates determined with monoclonal antibodies Silvia.

Cross section of the brain of a mouse with cryptococcal meningoencephalitis. Cross section of the brain of a mouse with cryptococcal meningoencephalitis.

Laboratory diagnosis of Clostridium difficile disease

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

Sexually acquired Zika virus: a systematic review

New developments in laboratory monitoring of HIV-1 infection

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Antimicrobial drug development – the past, the present, and the future

Clinical Microbiology and Infection

J.M. García-Lechuz, M. Sánchez-Conde, L. Muñoz, C. Benito

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity R.J.L.F. Loffeld, C.A.P.M.J.

Typing of Clostridium difficile

Presentation transcript:

Table 4 Results of 3 pairwise comparisons of expanded virus groups, by use of least-squares means differences and the Tukey honestly significant difference test From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Table 3 Results of 3 pairwise comparisons of conservative virus groups, by use of least-squares means differences and the Tukey honestly significant difference test From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Figure 3 Representative sagittal cross-sections of brains from rats inoculated with attenuated mumps vaccine virus (Jeryl Lynn, left), partially attenuated mumps vaccine virus (Urabe-AM9, middle), and wild-type mumps virus strains (88–1961, right). Arrows enlarged lateral ventricles From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Figure 2 Arcsin-transformed mean neurovirulence scores, as determined for each virus strain at each laboratory. FDA, Food and Drug Administration; NIBSC, National Institute for Biological Standards and Control From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Figure 1 Determination of neurovirulence score by use of a sagittal cross-section of the left hemisphere of a rat brain From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Table 2 Virus titers determined by each laboratory From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Table 1 Mump virus strains used From: The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study J Infect Dis. 2005;191(7):1123-1128. doi:10.1086/428098 J Infect Dis | © 2005 by the Infectious Diseases Society of America